On the recordMarch 11, 2015
That does not seem the way it should be. I would hope FDA would commit to complete the rulemaking...
Source
congress.govEditor's note · Context
Leahy criticizes the FDA's proposed rule for generic drug labeling and urges for timely updates.
Share
More from Patrick Leahy
Dec 1, 2022
while the distinguish leader is still on the floor, let me thank him for those remarks. And I know Marcelle will thank him too. Of course, our spouses have spent a lot of time together, and we know who the real leaders are in the house. I…
Dec 20, 2022
reserving the right to object, and I will object. I agree with the Senator from Florida that we have a responsibility to help Americans in the wake of disasters. It does not matter if you are a Republican or a Democrat or if you are from a…
Apr 21, 2023
I can say with absolute certainty that the proposed rules directly conflict with the legislation on a variety of matters, especially on provisions that limit access to the PTAB.
Mar 22, 2023
Do not turn your material, do not turn your reports over to the Executive Branch and let them tell you what is or is not classified.
Other voices in this conversation
